Clinicians providing care to elderly patients must appreciate the subt
le clinical manifestations that herald the onset of life-threatening i
nfectious disease. Aged patients with an infection may have neither fe
ver nor leucocytosis, making diagnosis challenging. Often, the early f
eatures of infectious disease are nonspecific and may resemble inflamm
atory or neoplastic processes, or there may be insufficient time to aw
ait definitive laboratory confirmation, and empirical antimicrobial tr
eatment must be initiated. Aging involves inevitable deleterious alter
ations in biological processes and, in many elderly patients, this is
most strongly characterised by diminished renal functional capacity. T
his has a major influence on antimicrobial prescribing in the elderly,
because therapeutic efficacy must be achieved while minimising the ri
sk of drug-related toxicity. Before prescribing an antibiotic to an ag
ed patient with an infection, the clinician must be cognisant of the p
atient's drug allergy history and the other drugs that the patient is
taking. Ignorance of potential drug-drug interactions can result in in
effective treatment or enhanced toxicity. The therapy of elderly patie
nts with infections is being expanded. To reduce costs and enhance the
efficiency of care, systems have been developed to provide antimicrob
ial care in the home and in long term care facilities. Home healthcare
has burgeoned, and drugs that are well tolerated, have a broad spectr
um of activity and are simple to administer (e.g. ceftriaxone and fluo
roquinolones) appear to be eminently suitable for this therapeutic rol
e. Physicians must also be informed of the factors responsible for the
emergence of resistant bacteria that are contributing to infections i
n institutional and community settings. Clinicians should strive to cu
rb inappropriate antibiotic use to stem the tide of infections that ar
e caused by multidrug-resistant bacteria.